Review
doi: 10.1016/s0891-5520(05)70397-4.
Drug resistance in tuberculosis
Affiliations
- PMID: 9421707
- DOI: 10.1016/s0891-5520(05)70397-4
Item in Clipboard
Review
Drug resistance in tuberculosis
Infect Dis Clin North Am.
1997 Dec.
Abstract
Drug-resistant tuberculosis remains a worldwide problem. New laboratory methods have improved our ability to more rapidly identify resistant strains, but the most effective approach is to prevent the appearance of resistance by appropriate choice of antibiotics and directly-observed therapy. Mycobacterium tuberculosis is treated with familiar and unique drugs; consequently, mechanisms of resistance have some unique features. All drug resistance thus far identified develops by mutational events rather than acquisition of resistance genes from other bacteria. An agenda is presented for countering the appearance of further drug resistance in mycobacteria.
Similar articles
-
[Bactericidal therapy in patients with tuberculosis].Probl Tuberk Bolezn Legk. 2004;(3):21-6. Probl Tuberk Bolezn Legk. 2004. PMID: 15338895 Russian. No abstract available.
-
Trench warfare in a battle with TB.Science. 2008 Jul 18;321(5887):362-4. doi: 10.1126/science.321.5887.362. Science. 2008. PMID: 18635790 No abstract available.
-
Tuberculosis in the context of emerging and reemerging diseases.FEMS Immunol Med Microbiol. 1997 Aug;18(4):263-9. doi: 10.1111/j.1574-695X.1997.tb01054.x. FEMS Immunol Med Microbiol. 1997. PMID: 9348161 Review. No abstract available.
-
Multiple drug-resistant tuberculosis.Infect Dis Clin North Am. 1998 Mar;12(1):157-72. doi: 10.1016/s0891-5520(05)70415-3. Infect Dis Clin North Am. 1998. PMID: 9494836 Review.
-
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].Probl Tuberk Bolezn Legk. 2007;(2):31-8. Probl Tuberk Bolezn Legk. 2007. PMID: 17419333 Russian.
Cited by
-
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.Clin Microbiol Rev. 2011 Apr;24(2):314-50. doi: 10.1128/CMR.00059-10. Clin Microbiol Rev. 2011. PMID: 21482728 Free PMC article. Review.
-
Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay.J Clin Microbiol. 2001 Oct;39(10):3736-9. doi: 10.1128/JCM.39.10.3736-3739.2001. J Clin Microbiol. 2001. PMID: 11574605 Free PMC article.
-
Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis.BMC Pulm Med. 2013 Apr 16;13:23. doi: 10.1186/1471-2466-13-23. BMC Pulm Med. 2013. PMID: 23590701 Free PMC article. Clinical Trial.
-
Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells.Infect Immun. 2001 Dec;69(12):7461-70. doi: 10.1128/IAI.69.12.7461-7470.2001. Infect Immun. 2001. PMID: 11705921 Free PMC article.
-
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.Respir Res. 2001;2(3):164-8. doi: 10.1186/rr54. Epub 2001 Apr 5. Respir Res. 2001. PMID: 11686881 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
